Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 3137 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

IVT patents DepoVax vaccine delivery system

According to the company, DepoVax vaccines are readily amenable to commercialization. They can be manufactured in large batches, and are well suited for large scale distribution and long

Qiagen and BioHelix sign licensing agreement

This licensing agreement adds a further amplification technology to Qiagen’s broad intellectual property estate of amplification and assay technologies that includes numerous PCR and PCR-similar technologies as well

3M and IDRI collaborate in vaccine research

Under the agreement, 3M will donate its patented toll-like receptor (TLR) immune response modifier compounds. 3M’s patented TLR immune response modifier compounds, which may be useful as vaccine

AmpliMed starts Phase II pancreatic cancer trial

The multicenter, randomized Phase II trial will evaluate Amplimexon (imexon for injection) plus gemcitabine versus gemcitabine plus placebo in approximately 124 chemotherapy naive patients with metastatic pancreatic cancer.

Syneron launches LipoLite device

For patients, LipoLite is both a minimally invasive alternative and a complement to traditional liposuction fat-removing procedures. According to the company, the procedure requires only local anesthetic and